Explore

Trendline Trendline
Erasca Shares Plummet Amid Patient Death and Patent Dispute

Erasca Shares Plummet Amid Patient Death and Patent Dispute

Erasca Shares Plummet Amid Patient Death and Patent Dispute
Trendline Trendline
Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline

Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline

Rosen Law Firm Urges Atara Biotherapeutics Investors to Join Securities Class Action Before Deadline
Trendline Trendline
ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims

ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims

ImmunityBio Faces Securities Fraud Lawsuit Over Misleading Cancer Drug Claims
Trendline Trendline
Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action

Kessler Topaz Meltzer Check, LLP Alerts ImmunityBio Investors of Securities Fraud Class Action
Trendline Trendline
FDA Approves Pfizer and Arvinas' Veppanu for Breast Cancer Treatment Despite Mixed Data

FDA Approves Pfizer and Arvinas' Veppanu for Breast Cancer Treatment Despite Mixed Data

FDA Approves Pfizer and Arvinas' Veppanu for Breast Cancer Treatment Despite Mixed Data
Trendline Trendline
Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments

Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments

Merck Ends Development of TROP ADC Amidst Strategic Pipeline Adjustments
Trendline Trendline
Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Progress

Summit Therapeutics Reports Q1 2026 Financial Results and Clinical Progress
Trendline Trendline
Summit Therapeutics Reports Q1 Financials and Progress in Cancer Drug Trials

Summit Therapeutics Reports Q1 Financials and Progress in Cancer Drug Trials

Summit Therapeutics Reports Q1 Financials and Progress in Cancer Drug Trials
Trendline Trendline
Pomerantz Law Firm Investigates Disc Medicine for Potential Securities Fraud

Pomerantz Law Firm Investigates Disc Medicine for Potential Securities Fraud

Pomerantz Law Firm Investigates Disc Medicine for Potential Securities Fraud
Trendline Trendline
Merck Reports Strong Q1 Results Driven by Keytruda Sales, Adjusts 2026 Outlook

Merck Reports Strong Q1 Results Driven by Keytruda Sales, Adjusts 2026 Outlook

Merck Reports Strong Q1 Results Driven by Keytruda Sales, Adjusts 2026 Outlook
Trendline Trendline
Eli Lilly's Stock Rises Following Strong Q1 Results and Raised Guidance

Eli Lilly's Stock Rises Following Strong Q1 Results and Raised Guidance

Eli Lilly's Stock Rises Following Strong Q1 Results and Raised Guidance
Trendline Trendline
FDA Panel Delivers Mixed Verdict on AstraZeneca's Cancer Drugs

FDA Panel Delivers Mixed Verdict on AstraZeneca's Cancer Drugs

FDA Panel Delivers Mixed Verdict on AstraZeneca's Cancer Drugs